Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now KOSDAQ - Delayed Quote • KRW Webzen Inc. (069080.KQ) Follow Compare 13,190.00 -350.00 (-2.58%) As of 10:00:07 AM GMT+9. Market Open. Related News Gold hits record high, oil prices fall Gold (GC=F) hit a record high as investors turn to commodities amid the ongoing trade war. Yahoo Finance Senior Business Reporter Ines Ferré joins Market Domination to discuss the price action in gold as well as oil (CL=F, BZ=F) and gas (RB=F). To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. Gold hits a new record as investors seek safe havens Gold hovers near another record as tariff turmoil continues to consume the market. GM, Tesla, & Ford; Nike falls; CarMax outlook: Trending Tickers Brad Smith and Madison Mills take a closer look at some of the trending tickers in premarket trading. UBS analysts downgrade General Motors (GM) to Neutral from Buy and cut their price target for Tesla (TSLA), while Goldman Sachs downgrades Ford (F) to Neutral from Buy. Nike (NKE) and Lululemon (LULU) fall, retreating from broad tariff pause highs, as investors assess the impact of increased tariffs on imports from China on retailers. CarMax (KMX) pulls its long-term sales forecast, citing macro-level uncertainty. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. Shinsegae opens 'The Heritage' where culture, history, and luxury converge in the heart of Seoul On April 9th, Shinsegae Department Store presents 'The Heritage,' a new iconic culture house in Myeong-dong•Namdaemun, where Seoul's rich history, luxury, and trends merge in a 90-year-old historical space. MSP Recovery Announces Strategic Term Sheet Providing Prospective Liquidity and Restructuring of Existing Agreements to Remove Corporate Guaranteed Debt by over $1.2 Billion as Well as New Agreements Aimed at Driving Future Growth MIAMI, April 10, 2025 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. (NASDAQ: MSPR) (“MSP Recovery” or the “Company”), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, is pleased to announce that it entered into a strategic term sheet (“Term Sheet”) agreeing to several restructuring transactions with Hazel Partners Holdings, LLC (“Hazel”), Virage Capital Management (“Virage”), and their respective affiliates. These initiatives are designed to reduce cos QQQ Pulls In $1.9 Billion of New Money During Historic Rally The Invesco QQQ Trust (QQQ) attracted $1.9 billion. Here are the daily ETF fund flows for April 9, 2025. These Stocks Moved the Most Today: Nvidia, Apple, Tesla, GM, Microsoft, CarMax, U.S. Steel, Warner Bros., and More Shares of Nvidia, Apple, and Tesla fall sharply Thursday after each stock soared double-digits Wednesday following President Donald Trump’s move to pause most reciprocal tariffs for 90 days. U.S. Steel, meanwhile, slumps after Trump says he wants the steel maker to remain an American company. S&P 500 Tumbles 3.5% After US-China Feud Heats Up: Markets Wrap (Bloomberg) -- Economic angst enveloped every corner of Wall Street as US-China trade tensions escalate, sparking a slide in stocks, the dollar and oil, with liquidations in US assets pointing to disorder in the financial system.Most Read from BloombergMidtown Office Building Evacuated on Concerns of Wall CollapseIn Chicago, a Former Steel Mill Looks to Make a Quantum LeapThe Secret Formula for Faster TrainsHelicopter Crashes Into Hudson River With Multiple FatalitiesInside the Quiet, Extravagan Why Summit Therapeutics Rallied Double Digits Today on Another Down day for the Markets Shares of lung cancer-focused biotech Summit Therapeutics (NASDAQ: SMMT) rallied 16.6% at its highs of the day before settling into a 10.4% gain on Thursday as of 3:54 p.m. EDT, even though the broader markets were down significantly on the day at that time, including the SPDR S&P Biotech ETF (NYSEMKT: XBI), which was down 4.4%. The interesting news for Summit was that two insiders exercised warrants on Summit's stock yesterday, which most interpreted as being highly bullish. What is notable is that the Co-CEOs exercised these warrants, forcing them to buy $6.3 million worth of shares, about four and a half years before the warrants' expiration in December of 2029. Why CarMax (KMX) Shares Are Plunging Today Shares of used automotive vehicle retailer Carmax (NYSE:KMX) fell 19.8% in the morning session after the company reported underwhelming Q1 2025 (fiscal Q4 2025) results. Its EBITDA missed significantly and its EPS fell short of Wall Street's estimates. More troubling, the company suspended its long-term growth guidance, citing macroeconomic uncertainty, a move that signaled management's reduced visibility and confidence in the future growth trajectory. Overall, this quarter could have been bette Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer Filing provisional patent application with the USPTO entitled “PSMA-Targeted PARP Inhibitor conjugates for Precision Cancer Therapy” key to advancement of Diagnostic and Therapeutic programs Dr. Alan Kozikowski, internationally acclaimed pioneer in the discovery of a critical PSMA targeting ligand for clinical applications is co-inventor Theranostic molecule designed to preferentially target prostate cancer cells to the effects of radiation and chemotherapeutic agents GAITHERSBURG, Md., April 10 These Stocks are Leading Losses Today Some of the biggest winners from yesterday’s rally have erased much of those gains today. Delta Air Lines logged a 23% gain yesterday. Today, shares have fallen more than 9%. Warner Bros. Discovery rose 20% Wednesday and has dropped roughly 13% in today’s trading. Novavax shares tumble after U.S. health secretary raises concerns over COVID shot's efficacy (Reuters) -Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and Human Services Secretary Robert F. Kennedy Jr. raised concerns about the company's COVID-19 vaccine in an interview with CBS News. The U.S. Food and Drug Administration, an agency that is part of the HHS, missed its deadline last week for deciding on the traditional approval of the vaccine. When asked if the delay resulted from "personnel being shuffled" at the FDA, Kennedy attributed it to the vaccine's composition. CarMax Stock Sinks After Earnings. Tariffs Could Drive Used Car Prices Higher, CEO Says. Shares of CarMax sank Thursday after the used-car dealer reported fiscal-fourth-quarter earnings that missed expectations and management sounded the alarm about the looming impact of auto tariffs. The tariff will expand to imported car parts starting May 3, making it more expensive to assemble vehicles in the United States. “I think it will it will push some folks into looking at used cars, late model used cars, which is interesting because that’s what we’re seeing a lot of interest in right now,” CarMax CEO William Nash said Thursday. Sector Update: Health Care Stocks Drop Thursday Afternoon Health care stocks were falling Thursday afternoon, with the NYSE Health Care Index shedding 4.4% an CarMax is the latest company to nix long-term growth targets on earnings call: ‘Why put a target out there?’ The company points to the "potential impact of broader macro factors." Used car stocks crash as demand flags and Goldman Sachs slashes autos outlook The U.S. auto sector is taking a beating. CarMax’s Share Buybacks Turned Lemonade Into Lemons: Heard on the Street Timing the market amid the recent tariff-fueled volatility is hard even for stock pickers buying shares of the companies they know best—themselves. A case in point: CarMax, the used-car dealer, which today announced quarterly earnings that missed analysts’ estimates. CarMax said it repurchased 1.2 million shares of common stock for $98.5 million, or about $82 a share, last quarter. Carmax Stock Heads for Worst Day Since 2022 CarMax shares slid after the used-car retailer missed earnings expectations and said it could no longer give a time frame for financial goals it has been working toward for years. Shares sank about 20% as of about midday Thursday, on pace for their biggest one-day drop since September 2022. Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report? Charles River (CRL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. Performance Overview Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) Return 069080.KQ KOSPI Composite Index (^KS11) YTD -3.79% -0.07% 1-Year -16.23% -11.42% 3-Year -37.88% -10.96%